COVID-19
The Latest
-
JN.1 Variant Surges as Dominant COVID-19 Strain in U.S. But Does Not lead to More Severe Disease
As the United States grapples with the pervasive spread of the JN.1 variant, the latest iteration of COVID-19, both the medical community and the public are bracing for its implications. 
As the United States grapples with the pervasive spread of the JN.1 variant, the latest iteration of COVID-19, both the medical community and the public are bracing for its implications. -
China CDC Assesses Low Public Health Risk from JN.1 Variant Amid Rising Respiratory Diseases
On December 28, the Chinese National Health Commission held a press conference regarding the prevention and treatment of respiratory diseases in winter. 
On December 28, the Chinese National Health Commission held a press conference regarding the prevention and treatment of respiratory diseases in winter. -
New COVID-19 Variant JN.1 Spreads Rapidly in the U.S. During Holiday Season
As the U.S. enters the Christmas season, a new COVID-19 variant, known as JN.1, is rapidly spreading across the country, potentially leading to an increase in infections this winter. Meanwhile, interest in vaccination among Americans appears to be waning. As the U.S. enters the Christmas season, a new COVID-19 variant, known as JN.1, is rapidly spreading across the country, potentially leading to an increase in infections this winter. Meanwhile, interest in vaccination among Americans appears to be waning. -
COVID-19 JN.1 Variant Emerges as Dominant Strain in Singapore, Rapidly Spreading in the U.S.
JN.1 has recently garnered attention, especially in Asia, where it has become the dominant strain in Singapore. The Singapore Ministry of Health reported that COVID-19 cases jumped from over 22,000 to 32,035 in the week ending December 2, with 60% of these cases being the JN.1 variant. JN.1 has recently garnered attention, especially in Asia, where it has become the dominant strain in Singapore. The Singapore Ministry of Health reported that COVID-19 cases jumped from over 22,000 to 32,035 in the week ending December 2, with 60% of these cases being the JN.1 variant. -
U.S. Allocates $600 Million for Free COVID-19 Test Kits: Here's What You Need to Know
The U.S. is reinstating some COVID-19 related measures. 
The U.S. is reinstating some COVID-19 related measures. -
New COVID-19 Strain EG.5 Earns Watchful Eye from WHO; Global Risk Remains Low
On August 9, the World Health Organization (WHO) upgraded the COVID-19 variant EG.5 to a "variant of interest." This decision indicates that the reputable health organization believes there should be continued monitoring and research into EG.5. On August 9, the World Health Organization (WHO) upgraded the COVID-19 variant EG.5 to a "variant of interest." This decision indicates that the reputable health organization believes there should be continued monitoring and research into EG.5. -
China's Expert Recommends COVID-19 Booster Shots for Vulnerable Populations, Optional for Under 50s
If no new coronavirus variants emerge after the XBB strain, the infection may gradually subside, with a low-level, persistent epidemic. However, if new variants continue to emerge, another wave of infection will follow. Those uninfected during the first wave face higher risk of infection during the second wave. For reinfection, people aged 60 and above and those unvaccinated are at greater risk. 
If no new coronavirus variants emerge after the XBB strain, the infection may gradually subside, with a low-level, persistent epidemic. However, if new variants continue to emerge, another wave of infection will follow. Those uninfected during the first wave face higher risk of infection during the second wave. For reinfection, people aged 60 and above and those unvaccinated are at greater risk. -
Chinese Scientist Challenges Prevailing Theories, Suggests Covid-19 Originated from Humans
Debates surrounding the origins of the novel coronavirus have led to various hypotheses, including the possibility of a leak from a Chinese lab or the virus originating from wildlife at Wuhan's wet market. Now, a Chinese scientist has presented a new theory that the virus may have originated from humans, refuting previous claims that Wuhan was the source of the outbreak. Debates surrounding the origins of the novel coronavirus have led to various hypotheses, including the possibility of a leak from a Chinese lab or the virus originating from wildlife at Wuhan's wet market. Now, a Chinese scientist has presented a new theory that the virus may have originated from humans, refuting previous claims that Wuhan was the source of the outbreak. -
WHO Director-General Urges China to Share COVID-19 Origins Data for a Clearer Understanding
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus called on China to share its information on the origins of COVID-19, stressing that without full access to this data, all hypotheses would remain open. World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus called on China to share its information on the origins of COVID-19, stressing that without full access to this data, all hypotheses would remain open. -
Crucial Insight into COVID-19 Origins Emerges from Chinese Data on Infected Animals in Wuhan Market
Researchers have analyzed previously unseen genomic samples from the early days of the COVID-19 pandemic, providing crucial insight into the outbreak's origins, including the presence of infected animals at the Huanan live animal market in Wuhan, China. Researchers have analyzed previously unseen genomic samples from the early days of the COVID-19 pandemic, providing crucial insight into the outbreak's origins, including the presence of infected animals at the Huanan live animal market in Wuhan, China.
